New England Biolabs

New England Biolabs® Pledges $100,000 to the Vaccine and Immunotherapy Center at Mass General Hospital

Retrieved on: 
Martedì, Maggio 26, 2020
Viruses, Microbiology, Zoonoses, New England Biolabs, Coronaviridae, NEB, Severe acute respiratory syndrome-related coronavirus, Middle East respiratory syndrome-related coronavirus, Severe acute respiratory syndrome, Coronavirus, Vaccine

IPSWICH, Mass., May 26, 2020 /PRNewswire/ -- New England Biolabs (NEB) has announced its pledge of $100,000 to the Vaccine and Immunotherapy Center (VIC) at Mass General Hospital (MGH).

Key Points: 
  • IPSWICH, Mass., May 26, 2020 /PRNewswire/ -- New England Biolabs (NEB) has announced its pledge of $100,000 to the Vaccine and Immunotherapy Center (VIC) at Mass General Hospital (MGH).
  • The funds will be used to support the search for a vaccine against the novel coronavirus, SARS-CoV-2, which causes the disease COVID-19.
  • "I am deeply appreciative of New England Biolabs' philanthropic support, which will be instrumental to our COVID-19 clinical research efforts."
  • NEB and NEW ENGLAND BIOLABS, are registered trademarks of New England Biolabs, Inc.
    View original content to download multimedia: http://www.prnewswire.com/news-releases/new-england-biolabs-pledges-100-...

New England Biolabs® Introduces 100% Recyclable Packaging for Cold Chain Shipping in Partnership with TemperPack®

Retrieved on: 
Lunedì, Aprile 27, 2020
Articles, Business, Food safety, Pharmaceutical industry, Temperature control, Life sciences, Packaging, Product management, New England Biolabs, NEB, Cold chain, Trademark

The new packaging was developed by TemperPack, a U.S. company that focuses on providing sustainable solutions for cold chain shipping.

Key Points: 
  • The new packaging was developed by TemperPack, a U.S. company that focuses on providing sustainable solutions for cold chain shipping.
  • While fully recyclable, this new packaging maintains the proper shipping temperature conditions for its products.
  • EPS has historically been the "gold standard" for cold shipping, as it is light, durable, and well-known for its insulative properties.
  • NEW ENGLAND BIOLABS and NEB are registered trademarks of New England Biolabs, Inc.
    CLIMACELL and TEMPERPACK are registered trademarks of TemperPack Technologies, Inc.
    View original content to download multimedia: http://www.prnewswire.com/news-releases/new-england-biolabs-introduces-1...

New England Biolabs® to Showcase Next Generation Sequencing Sample Preparation Innovations at AGBT™ 2020

Retrieved on: 
Venerdì, Febbraio 21, 2020
Branches of biology, Molecular biology, Biochemistry, Biology, New England Biolabs, RNA-Seq, NEB, Gene expression, Sequencing, Polymerase chain reaction

Of particular note is the growing collection of RNA-seq sample prep reagents, including several advances in RNA depletion options.

Key Points: 
  • Of particular note is the growing collection of RNA-seq sample prep reagents, including several advances in RNA depletion options.
  • For other sample types, a web-based design tool for customizable RNA depletion will be described.
  • NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis.
  • NEB, NEW ENGLAND BIOLABS, and NEBNEXT are registered trademarks of New England Biolabs, Inc. EM-SEQ and ULTRAare trademarks of New England Biolabs, Inc. AGBT is a trademark of The Genome Partnership.

New England Biolabs® to present novel solutions to support agricultural biology at Plant and Animal Genome Meeting

Retrieved on: 
Venerdì, Gennaio 10, 2020
Branches of biology, Biology, Life sciences, DNA sequencing, Genetics, Molecular biology, Genotyping, Illumina, Inc., New England Biolabs, Molecular breeding, NEB

The NEBNext Direct Genotyping Solution presents a novel NGS-based targeted genotyping approach, with advantages in both cost and throughput.

Key Points: 
  • The NEBNext Direct Genotyping Solution presents a novel NGS-based targeted genotyping approach, with advantages in both cost and throughput.
  • Focused initially on marker assisted breeding, the technology is capable of genotyping between 100-5,000 markers in parallel, using a unique, capture-based enrichment approach.
  • "Genotyping for molecular breeding requires solutions that can support robust processes in order to implement at scale," stated Bjoern Textor, Ph.D., Senior Application Specialist at NEB GmbH.
  • NEW ENGLAND BIOLABS, NEB and NEBNEXT are registered trademarks of New England Biolabs, Inc.
    ILLUMINA is a registered trademark of Illumina, Inc.
    View original content to download multimedia: http://www.prnewswire.com/news-releases/new-england-biolabs-to-present-n...

ERS Genomics Announces Agreement With New England Biolabs to Commercialize CRISPR Gene Editing Tools and Reagents

Retrieved on: 
Martedì, Gennaio 7, 2020
Science, Stem cells, Biotechnology, Practice Management, Research, Health, Medical devices, Genetics, Branches of biology, Biology, Life sciences, Genome editing, Immune system, Genetic engineering, Enzymes, Biotechnology, CRISPR, Cas9, New England Biolabs, Human Nature

As a provider of CRISPR/Cas9 reagents and tools, NEBs license from ERS Genomics expands the Companys rights to use and sell these technologies.

Key Points: 
  • As a provider of CRISPR/Cas9 reagents and tools, NEBs license from ERS Genomics expands the Companys rights to use and sell these technologies.
  • ERS Genomics holds an exclusive worldwide license from Dr. Charpentier to the foundational IP covering CRISPR/Cas9.
  • New England Biolabs is a recognized world leader in the discovery and production of enzymes for molecular biology applications, stated Eric Rhodes, CEO of ERS Genomics.
  • For more information about ERS Genomics, visit www.ersgenomics.com
    For more information about CRISPR/Cas9 reagents available from New England Biolabs, visit www.neb.com/GenomeEditing
    View source version on businesswire.com: https://www.businesswire.com/news/home/20200107005858/en/

New England Biolabs® Announces the Donald G. Comb Honorary Lectureship Series in Celebration of Company Founder

Retrieved on: 
Lunedì, Novembre 18, 2019
Branches of biology, Life sciences, Biology, Cell biology, Protein structure, Electron microscopy, New England Biolabs, Cryogenic electron microscopy, NEB, Cryo

The University of California, Berkeley's, Eva P. Nogales, a pioneer in the application of cryogenic electron microscopy (Cryo-EM), will kick off the Donald G. Comb Honorary Lectureship series at New England Biolabs, in Ipswich, MA, on November 20th, 2019.

Key Points: 
  • The University of California, Berkeley's, Eva P. Nogales, a pioneer in the application of cryogenic electron microscopy (Cryo-EM), will kick off the Donald G. Comb Honorary Lectureship series at New England Biolabs, in Ipswich, MA, on November 20th, 2019.
  • Cryo-EM is a technique that bridges the gap between molecules and cells, allowing the study of large protein complexes that operate in living cells.
  • "Dr. Nogales is a worthy choice for our inaugural Donald G. Comb Honorary Lectureship," said Thomas C. Evans, Jr., Ph.D. and Executive Director of Research.
  • NEW ENGLAND BIOLABS and NEB are registered trademarks of New England Biolabs, Inc.
    View original content to download multimedia: http://www.prnewswire.com/news-releases/new-england-biolabs-announces-th...

New England Biolabs Ranked #1 By Scientists in Customer Experience Survey

Retrieved on: 
Martedì, Agosto 20, 2019
Marketing, Customer experience, Brand management, Business, Microeconomics, Services marketing, Touchpoint, Benchmarking, New England Biolabs, Bioinformatics

ARLINGTON, Va., Aug. 20, 2019 /PRNewswire-PRWeb/ -- Scientists ranked New England Biolabs number one in overall customer experience for the second time since BioInformatics first fielded the survey in 2016.

Key Points: 
  • ARLINGTON, Va., Aug. 20, 2019 /PRNewswire-PRWeb/ -- Scientists ranked New England Biolabs number one in overall customer experience for the second time since BioInformatics first fielded the survey in 2016.
  • The results are published in the newest report, Benchmarking for 2019: Life Science Customer Experience , from BioInformatics, part of Science and Medicine Group.
  • More than 800 life scientists were asked to rank their experience with their laboratory suppliers for each of 18 critical touchpoints across the entire customer journey the prepurchase, purchase, and postpurchase phases.
  • The report compares the corporate performance at each touchpoint and calculates an overall Customer Experience Score for each of 27 suppliers.

New England Biolabs®, Inc. opens eighth subsidiary in Australia

Retrieved on: 
Mercoledì, Luglio 3, 2019
NEB, New England Biolabs, Life sciences, Industries, Biotechnology

"NEB Australia are looking forward to working with our customers to accelerate the next ground-breaking discovery, making a difference in our local communities and showcasing our Australian research talent to the world."

Key Points: 
  • "NEB Australia are looking forward to working with our customers to accelerate the next ground-breaking discovery, making a difference in our local communities and showcasing our Australian research talent to the world."
  • "We are excited to expand our subsidiary network into Australia," stated Carole Keating, Director of International Business at NEB.
  • NEB also maintains subsidiary offices in Canada, China, France, Germany, Japan, Singapore and the United Kingdom.
  • NEW ENGLAND BIOLABS and NEB are registered trademarks of New England Biolabs, Inc.
    View original content to download multimedia: http://www.prnewswire.com/news-releases/new-england-biolabs-inc-opens-ei...

New England Biolabs® expands its Monarch Nucleic Acid Purification portfolio with a genomic DNA extraction and purification kit

Retrieved on: 
Mercoledì, Maggio 15, 2019
Molecular biology, Natural sciences, Life sciences, Branches of biology, New England Biolabs, NEB, Nucleic acid methods, Polymerase chain reaction

IPSWICH, Mass., May 15, 2019 /PRNewswire/ --New England Biolabs (NEB) today announced the release of its Monarch Genomic DNA Purification Kit.

Key Points: 
  • IPSWICH, Mass., May 15, 2019 /PRNewswire/ --New England Biolabs (NEB) today announced the release of its Monarch Genomic DNA Purification Kit.
  • The Monarch Genomic DNA Purification Kit complements NEB's qPCR, PCR and NGS workflows, and can be utilized with these product lines accordingly.
  • For more details about the Monarch Nucleic Acid Purification Kits, or to request a free trial kit, visit NEBMonarch.com .
  • NEB and NEW ENGLAND BIOLABS are registered trademarks of New England Biolabs, Inc.
    MONARCH is a registered trademark of New England Biolabs, Inc.
    View original content to download multimedia: http://www.prnewswire.com/news-releases/new-england-biolabs-expands-its-...

New England Biolabs® launches myNEB™, a first of its kind voice-activated digital lab assistant for Alexa

Retrieved on: 
Venerdì, Maggio 3, 2019
NEB, New England Biolabs, Alexa Internet, Alexa, Industries, Business

myNEB, an Alexa cloud-based voice service, released today by New England Biolabs (NEB), has the answers you need.

Key Points: 
  • myNEB, an Alexa cloud-based voice service, released today by New England Biolabs (NEB), has the answers you need.
  • This first of its kind, voice-activated digital lab assistant will help researchers and technicians with basic reagent-based calculations and scientific information, while they are engaged in lab work.
  • "We're excited to introduce Alexa into the lab," said Penny Devoe, Associate Director, Portfolio Management, DNA Cloning at NEB.
  • NEB and NEW ENGLAND BIOLABS are registered trademarks of New England Biolabs, Inc.
    MYNEB is a trademark of New England Biolabs, Inc.
    View original content to download multimedia: http://www.prnewswire.com/news-releases/new-england-biolabs-launches-myn...